Partner Content Partner Content J+D Forecasting strike the balance for the liquid tumour mar... Greater confidence in outputs and decision-making
Partner Content Partner Content P360 Adds Advanced Artificial Intelligence Capabilities to i... Introducing BirdzAI by P360
Partner Content Partner Content Insights From GMA Interactions We are all familiar with the valuable insights that MSLs bring in from the field. But what about insights from Medical Affairs interactions?
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
